Zoe Loh Awarded Bass Fellowship
Zoe Loh, a third-year doctoral student in the Department of Pathology, has been awarded the Bass Instructor of Record Fellowship. The Bass Fellowship supports high-quality teaching experiences for PhD students where normal means of funding are unavailable.
McCall to Co-direct New Precision Cancer Medicine Research Program
The Duke Cancer Institute has announced a reconfiguration of its National Cancer Institute-Designated Research Programs effective January 1, 2021.
Chen Receives Mark Slive Foundation Award
The Mike Slive Foundation has awarded a grant to Ming Chen, PhD to test whether the induction of ferroptosis can help slow the growth of neuroendocrine prostate cancer in preclinical animal models and to determine how it works.
Pavlisko Chosen for Leadership Program
Elizabeth N. Pavlisko, MD has been selected as a Duke Clinical Leadership Program (DCLP) Fellow.
New! The 2020 Fall Newsletter is Published
"The Pathology Report" our 2020 Fall Newsletter, is ready for you. Check it out on Issuu to read and download.
Park Receives Prostate Cancer Foundation Award
Jung Wook Park, PhD, holder of the endowed Rollie Assistant Professorship in Correlative Pathology, was named recently as one of 27 recipients nationwide of the Class of 2020 Young Investigator Award from the Prostate Cancer Foundation (PCF).
Young to Assume Chief Roles in Hematopathology
I am very pleased to appoint Ken H. Young, MD PhD, as Chief of Hematopathology Division and DCI Blood Cancer Pathology Service, effective January 1, 2021.
Barisoni Featured for Digital Nephropathology Research
Laura Barisoni, MD, co-director of the Division of AI/Computational Pathology and newly appointed Director of the Renal Pathology Service in the Department of Pathology, has dedicated the last decade of her professional life in implementing digital pathology and image analysis to study kidney diseases.
Pavlisko Promoted to Associate Professor
Elizabeth Pavlisko, MD has been promoted to the rank of Associate Professor Pathology.
Pathology Engaged in Statewide COVID-19 Analysis
Duke Pathology is engaged in a statewide initiative to analyze COVID-19 specimens, to advance understandings of the mechanisms of the virus and help to find a cure.